To overcome these resistances, drugs with novel modes of action are urgently needed. Researchers at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) have now uncovered the mode ...

Research led at Dana-Farber in Boston by Jennifer Chan, MD, MPH, supports an FDA approval for cabozantinib for previously treated patients with advanced neuroendocrine tumors. Boston ...

Abstract: Skeleton sequences for action recognition are with complex temporal dynamics ... To capture this complex motion pattern effectively, we propose a Dual Multi-Scale Graph Convolutional Network ...